Business Context and Reporting Period
This Form 8-K Current Report from Supernus Pharmaceuticals, Inc. (SUPN) covers the Annual Meeting of Stockholders held on June 16, 2023. The report details the voting results for four proposals submitted to shareholders. As of April 17, 2023, there were 54,476,409 shares of common stock outstanding and entitled to vote.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document is strictly a report on corporate governance voting outcomes.
Material Changes and Voting Results
The filing reports the following outcomes for the shareholder proposals:
- Proposal 1 (Election of Class II Directors):
- Frederick M. Hudson: Elected with 47,052,910 votes for; 1,761,870 votes withheld.
- Charles W. Newhall, III: Elected with 36,757,500 votes for; 12,057,280 votes withheld.
- Proposal 2 (Executive Compensation - Say on Pay): Approved with 47,347,143 votes for; 1,453,112 votes against.
- Proposal 3 (Frequency of Say on Pay): Shareholders voted to hold the advisory vote every 1 year (46,237,227 votes), compared to 2 years (10,676 votes) or 3 years (2,555,173 votes).
- Proposal 4 (Ratification of Auditors): KPMG LLP was ratified as the independent public accounting firm with 50,561,495 votes for; 379,954 votes against.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, risks, contingencies, or unusual items. It serves solely to disclose the results of the shareholder vote.
Investor Verification Checklist
- Verify the specific terms of the Class II Director elections and their tenure until 2026.
- Review the definitive proxy statement filed on May 1, 2023, for detailed context on the executive compensation and auditor ratification proposals.
- Confirm the total number of shares outstanding (54,476,409) as of the record date of April 17, 2023.
- Note the significant number of votes withheld for Director Charles W. Newhall, III (approx. 22% of votes cast on that specific nominee).